274 related articles for article (PubMed ID: 26402390)
1. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
Roland CL; Ye X; Stevens V; Oderda GM
J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
[TBL] [Abstract][Full Text] [Related]
3. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.
Kirson NY; Shei A; Rice JB; Enloe CJ; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
Pain Med; 2015 Jul; 16(7):1325-32. PubMed ID: 25929289
[TBL] [Abstract][Full Text] [Related]
4. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
[TBL] [Abstract][Full Text] [Related]
5. The Economic Burden of Opioid Abuse: Updated Findings.
Kirson NY; Scarpati LM; Enloe CJ; Dincer AP; Birnbaum HG; Mayne TJ
J Manag Care Spec Pharm; 2017 Apr; 23(4):427-445. PubMed ID: 28345440
[TBL] [Abstract][Full Text] [Related]
6. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
[TBL] [Abstract][Full Text] [Related]
7. Direct costs of opioid abuse in an insured population in the United States.
White AG; Birnbaum HG; Mareva MN; Daher M; Vallow S; Schein J; Katz N
J Manag Care Pharm; 2005; 11(6):469-79. PubMed ID: 15998164
[TBL] [Abstract][Full Text] [Related]
8. High-Cost Sarcoidosis Patients in the United States: Patient Characteristics and Patterns of Health Care Resource Utilization.
Rice JB; White A; Lopez A; Nelson WW
J Manag Care Spec Pharm; 2017 Dec; 23(12):1261-1269. PubMed ID: 29172980
[TBL] [Abstract][Full Text] [Related]
9. Opioid Abuse: A Detailed Examination of Cost Drivers over a 24-Month Follow-up Period.
Scarpati LM; Kirson NY; Jia ZB; Wen J; Howard J
J Manag Care Spec Pharm; 2017 Nov; 23(11):1110-1115. PubMed ID: 29083966
[TBL] [Abstract][Full Text] [Related]
10. Drivers of excess costs of opioid abuse among a commercially insured population.
Scarpati LM; Kirson NY; Zichlin ML; Jia ZB; Birnbaum HG; Howard JC
Am J Manag Care; 2017 May; 23(5):276-282. PubMed ID: 28738684
[TBL] [Abstract][Full Text] [Related]
11. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
Wei W; Gandhi K; Blauer-Peterson C; Johnson J
J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
[TBL] [Abstract][Full Text] [Related]
12. Direct Costs of Opioid Abuse in an Insured Population in the United States.
White AG; Birnbaum HG; Mareva MN; Daher M; Vallow S; Schein J; Katz N
J Manag Care Spec Pharm; 2020 Oct; 26(10):1188-1198. PubMed ID: 32996392
[TBL] [Abstract][Full Text] [Related]
13. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
[TBL] [Abstract][Full Text] [Related]
14. Natural Language Processing-Identified Problem Opioid Use and Its Associated Health Care Costs.
Masters ET; Ramaprasan A; Mardekian J; Palmer RE; Gross DE; Cronkite D; Von Korff M; Carrell DS
J Pain Palliat Care Pharmacother; 2018; 32(2-3):106-115. PubMed ID: 30702378
[TBL] [Abstract][Full Text] [Related]
15. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit.
Xie L; Joshi AV; Schaaf D; Mardekian J; Harnett J; Shah ND; Baser O
Pain Pract; 2014 Jun; 14(5):446-56. PubMed ID: 23809064
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of prescription opioid misuse and abuse.
Strassels SA
J Manag Care Pharm; 2009 Sep; 15(7):556-62. PubMed ID: 19739878
[TBL] [Abstract][Full Text] [Related]
17. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
Kaur AD; McQueen A; Jan S
J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
[TBL] [Abstract][Full Text] [Related]
18. Cost drivers of prescription opioid abuse in commercial and Medicare populations.
Pasquale MK; Joshi AV; Dufour R; Schaaf D; Mardekian J; Andrews GA; Patel NC
Pain Pract; 2014 Mar; 14(3):E116-25. PubMed ID: 24268019
[TBL] [Abstract][Full Text] [Related]
19. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
20. The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Womens Health (Lond); 2020; 16():1745506520965898. PubMed ID: 33357086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
